Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:fampridine
|
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
N07XX07
|
| gptkbp:form |
prolonged-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fampyra
|
| gptkbp:improves |
walking ability in multiple sclerosis patients
|
| gptkbp:manufacturer |
gptkb:Biogen
|
| gptkbp:mechanismOfAction |
potassium channel blocker
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:Biogen
|
| gptkbp:bfsLayer |
5
|